Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease - Wikidata - awgldk - TriplyDB

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

http://www.wikidata.org/entity/Q22242053

about

A proposed classification of the immunological diseases Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification New serological markers in inflammatory bowel disease are associated with complicated disease behaviour Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype Antibody markers in the diagnosis of inflammatory bowel disease Host-microbiome interaction in Crohn's disease: A familiar or familial issue?Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives Predicting and preventing autoimmunity, myth or reality?Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a mul Anti-Saccharomyces cerevisiae antibodies in coeliac disease Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.Molecular cloning reveals nearly half of patients with Crohn's disease have an antibody to peroxiredoxin 6-like protein.Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.Anti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity.Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis.Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease Current and future role of biomarkers in Crohn's disease risk assessment and treatment.Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.Increased levels of anti-glycan antibodies in patients with cystic fibrosis.Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease Comment on: Dietary yeast reduce inflammation in central nerve system via microflora.Anti-glycan antibodies as biomarkers for diagnosis and prognosis.IBD serological panels: facts and perspectives.Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.Current understanding of fungal microflora in inflammatory bowel disease pathogenesis New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.Inflammatory bowel disease serology in Asia and the West.New serological biomarkers of inflammatory bowel disease.The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases.Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

P2860

Q21144701-B81AC4B9-61BF-4BD6-A77B-141D4A9F5080 Q22241487-0E53229F-E72C-4F00-9AC4-30F6B5DDC382 Q22242048-CFC6454C-C1C7-4B88-8BA4-3822EF2B30A4 Q22251117-E01B48C3-EC97-4372-8D21-5569056A9480 Q26774452-C823A895-6B15-4D40-855D-82E40BD377EF Q26776158-CA458AE1-B771-43ED-83A1-E7C3B517EDF4 Q27000411-15F68AD6-EC33-40BE-BF88-7DDE02DC9AF1 Q27003192-2B1F55E4-33F6-4D6C-B321-F90ED6F02F07 Q27003201-91B57B0A-17FD-48D3-99F9-81786B7155B0 Q28085134-91A3F21A-6E7C-4038-93A1-7A5D4F32E91C Q28199608-9F2365E8-A545-4430-8F92-BA83A6E9690F Q28236862-88FEF90E-3208-484E-BC2C-C4C08FB4CF02 Q28300602-8370B39D-954A-4541-89EF-C61605E868C1 Q28303013-F084A2E9-387C-4E56-9BA8-47D3D973161B Q28305627-BCBCE3D4-04C3-4911-8EC9-62F9D8120ED2 Q28740412-5D8DFD86-6D7A-4E2C-85D2-506BCE5EAA32 Q33761406-F51D82F3-A038-4A9A-A5C4-A4A5521EE006 Q34230939-74665E01-AAFA-401F-9733-1E7258EF85FB Q34258150-B122C082-F15E-4B5E-8560-83FAA61BA23E Q34471099-6E83059D-DA1A-4EA0-9464-3E13299477EE Q34537607-6CC3D14B-2D6D-4F0D-846D-DBE4C1AEFE39 Q34962856-FA3BDF5C-EAA5-48C0-94FB-250B558239BB Q35058495-AB769DDA-9037-4795-9070-1CDA1F7730FA Q35095265-4D2A7DCC-D2B5-42FA-BC46-F7AEEE26E928 Q35666254-8DCCCB14-B755-4A69-A0F6-94D20C67A98A Q35668237-1C3BB01B-4C16-42D1-854D-F838AE6BAEE2 Q35748693-35D15AD3-D224-458D-91D3-739F4FDB9E81 Q35959693-96FE978C-14E0-4D78-863F-296F45E4B035 Q36172755-E20E0DF2-68D9-4A9B-9164-25391F093AC4 Q36410375-64E1C831-4156-44BA-8ABC-0D21AA4462AA Q36560795-6464EF5C-46C3-4216-A6A0-A98AA226D20A Q36884782-0AE9D56D-5BA6-48AA-A1B7-0785C3B4E0AA Q36923866-93BD8267-58DD-46E0-A676-6968C0FE0227 Q37064590-0F63FDA0-1283-4FAD-8998-C9BBD1FA1E94 Q37089171-2FABE7B1-3893-49F6-A419-D40FE4E9EF43 Q37206175-66698260-F26C-45DD-87B3-F1B033BC91AD Q37208122-49EFB982-632A-4DA1-8B1B-BABC767F1DF5 Q37262989-D49D14EE-7DFA-4B94-B23F-D4754271BB89 Q37288640-88ABDB4E-C415-4D94-B3C6-2BCF0A2DC040 Q37305418-6079166F-D214-4A65-9E10-C85F1154F844

P2860

Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease

http://www.wikidata.org/entity/Q22242053

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@ast

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@en

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@en-gb

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@nl

type

label

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@ast

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@en

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@en-gb

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@nl

prefLabel

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@ast

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@en

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@en-gb

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@nl

P1433

Q22242053-737EC9D1-EB4D-4D32-9537-4BF86702EE25

P1476

Q22242053-07B85A47-9BCE-4AC5-92F1-DB627BE98CA0

P2093

Q22242053-14AC488C-13F7-452F-A639-8E92283B4201

Q22242053-31AB3235-C8DA-4DA4-AB0F-FFFF45767B7A

Q22242053-31D58932-2A01-4270-B7C6-3D87BC06314C

Q22242053-7F36F375-EDE6-4D29-9AC6-A6A476930B9D

P2860

Q22242053-02D113FC-8856-4603-95B5-7891F51CEEF6

Q22242053-164A3B4F-8E48-4A82-9C47-1A75E439F5AB

Q22242053-16E7E798-B962-435C-BEA6-4FD4D820CD41

Q22242053-24291199-62BE-4F21-9202-A37295646885

Q22242053-33E8BD82-B2E0-4109-86E8-80FD40DBD070

Q22242053-3E4C708E-9772-4B5E-A74B-E8EDCB9FC980

Q22242053-4B21CDCC-D4CB-4E36-9862-A238F6AB5DBB

Q22242053-4B5FEF9F-8E9E-4AF5-9086-D357CF47B42D

Q22242053-52CBEE1C-AD81-4459-80BB-7C9FE7C1BA20

Q22242053-5F8ACAFE-E74C-4230-82FE-CF463357A910

P304

Q22242053-327CF62F-6044-4CF1-A7FC-1D47E23FEB2D

P31

Q22242053-40435C59-3669-479D-BC0D-DBB1AE4836EB

P3181

Q22242053-32193DCE-0FCA-4EAC-94AD-DE516F65BC89

P356

Q22242053-F932C37C-C473-4F5E-BECE-D7BE4E913BF0

P407

Q22242053-54C5BA85-1AB0-4C90-A2F4-04C5D2102263

P433

Q22242053-8969FC04-A9A2-4D4F-A834-2A917B857989

P478

Q22242053-1434DBF9-86F6-42FD-826D-A049CF6C8825

P50

Q22242053-E9AC369A-1C63-4053-A9DC-34F2EE7811AA

Q22242053-EB13C627-EA64-4A49-AA6E-4559F635D128

Q22242053-F0805CF4-18F5-433B-9960-0121813593CA

P577

Q22242053-28FF9096-B09C-4964-810A-FCC02C82537E

P5875

Q22242053-91C7FB4A-4B7C-4C6F-8E32-225E859A0142

P698

Q22242053-6E23655A-76D1-4DA6-A30B-DA879769F218

P921

Q22242053-4003D459-73C2-4220-8CFD-C4407DD94051

Q22242053-745B7AF8-AF9A-4940-A3C5-685EE1D400FE

Q22242053-A03CB75D-91E2-4AAD-A8AB-A22F4EF80E1F

Q22242053-E81100A5-5508-4E09-BDF1-87CE27338D22

P932

Q22242053-C7379DC5-758B-48CD-8D22-5B75E1ADE6BB

P3181

P356

GUT.2004.060228

P1433

P1476

Anti-Saccharomyces cerevisiae ...... of inflammatory bowel disease

@en

P2093

A Wiik

http://www.w3.org/2001/XMLSchema#string

E Goldin

http://www.w3.org/2001/XMLSchema#string

I Grotto

http://www.w3.org/2001/XMLSchema#string

R D Balicer

http://www.w3.org/2001/XMLSchema#string

P2860

Specific antibody response to oligomannosidic epitopes in Crohn's disease

Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study

Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

Lack of current clinical value of serological testing in the evaluation of patients with IBD.

Autoantibodies as predictors of disease.

Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.

Clustering of increased small intestinal permeability in families with Crohn's disease.

Serological markers in inflammatory bowel diseases.

Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases.

P304

1232-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3341618

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/GUT.2004.060228

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Yehuda Shoenfeld

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7660325

http://www.w3.org/2001/XMLSchema#string

P698

16099791

http://www.w3.org/2001/XMLSchema#string

P921

Saccharomyces cerevisiae

inflammatory bowel diseases

P932

1774672

http://www.w3.org/2001/XMLSchema#string